Abstract:Non-alcoholic fatty liver disease (NAFLD) is affecting up to one-third of the general population in western countries. While the major cause of NAFLD is related to an unhealthy lifestyle, recent evidence has shown a role of chemical exposure in the induction and progression of NAFLD. Perfluorooctanoate (PFOA) is a ubiquitous environmental contaminant that exerts its hepatotoxicity mainly through the activation of peroxisome proliferator-activated receptor α (PPARα). We examined how PFOA might affect the progression of NAFLD and whether a preexisting fatty liver intensified or alleviated the effects of PFOA in the livers. As such, male C57BL/6 mice were fed with a low-fat control diet (CD) or a high fat diet (HFD) for 16 weeks to model normal or steatotic livers, respectively. Mice were then administered with PFOA (1mg/kg/d) by oral gavage for an additional 2, 8, and 16 weeks. Dietary treatment was continued throughout the whole study. We found HFD induced hepatic steatosis, lobular inflammation, and progressive fibrosis in mice. As expected, PFOA activated PPARα, constitutive androstane receptor (CAR) and pregnane X receptor (PXR), regardless of the diet. Gene expression analysis showed the interactions between HFD and PFOA on hepatic nuclear receptors were time-dependent. Hepatocytes growth as measured by DNA synthesis and cell growth genes induced by PFOA were exacerbated in the HFD group after 2 weeks, along with the enhanced activation of PPARα. In contrast, PFOA decreased the severity of hepatic steatosis. In HFD-fed mice, the hepatic triglyceride levels were reduced to 75%, 47%, and 40%, after 2, 8, and 16 weeks of PFOA treatment, respectively, compared to vehicle controls. Transcriptomic analysis showed the preexisting NAFLD enhanced PFOA related lipid oxidation pathways in mice. HFD induced hepatic fibrosis as measured by collagen staining and fibrosis gene markers were also attenuated by PFOA. Taken together, this study demonstrated that the preexisting NAFLD might impact on many biological effects induced by PFOA and thus need to be carefully considered as a factor in risk assessment.

Microgram-order Ammonium Perfluorooctanoate May Activate Mouse Peroxisome Proliferator-Activated Receptor Alpha, but Not Human PPARalpha.

Modulation Of Ammonium Perfluorooctanoate-Induced Hepatic Damage By Genetically Different Ppar Alpha In Mice

Modulation of ammonium perfluorooctanoate-induced hepatic damage by genetically different PPARα in mice

Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor α agonists

Human Peroxisome Proliferator-activated Receptor Α (pparα) Supports the Induction of Peroxisome Proliferation in PPARα-deficient Mouse Liver

Species Differences between Mouse and Human PPARα in Modulating the Hepatocarcinogenic Effects of Perinatal Exposure to a High-Affinity Human PPARα Agonist in Mice

Ammonium perfluorooctanoate may cause testosterone reduction by adversely affecting testis in relation to PPARα.

Activation of human nuclear receptors by perfluoroalkylated substances (PFAS)

Activation of sterol regulatory element-binding proteins in mice exposed to perfluorooctanoic acid for 28 days

Effects of Peroxisome Proliferators PFOA on Immune System of Mice

Comparison of transcriptomic profiles between HFPO-DA and prototypical PPARα, PPARγ, and cytotoxic agents in mouse, rat, and pooled human hepatocytes

Perfluorooctanoic acid (PFOA) affects distinct molecular signalling pathways in human primary hepatocytes

The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.

Acot1 is a Sensitive Indicator for PPARα Activation after Perfluorooctanoic Acid Exposure in Primary Hepatocytes of Sprague-Dawley Rats

Evaluating the mode of action of perfluorooctanoic acid-induced liver tumors in male Sprague-Dawley rats using a toxicogenomic approach

Effect of PFOA on DNA Methylation and Alternative Splicing in Mouse Liver

Circulating Microrna Profiles Altered in Mice after 28 D Exposure to Perfluorooctanoic Acid.

Hepatotoxic Effects of Hexafluoropropylene Oxide Trimer Acid (HFPO-TA), A Novel Perfluorooctanoic Acid (PFOA) Alternative, on Mice

Relationship between peroxisome proliferator-activated receptor alpha activity and cellular concentration of 14 perfluoroalkyl substances in HepG2 cells

Induction of Hepatic Mir-34A by Perfluorooctanoic Acid Regulates Metabolism-Related Genes in Mice.

Comparative Hepatotoxicity of Novel PFOA Alternatives (Perfluoropolyether Carboxylic Acids) on Male Mice.